CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $338,791 | +19.0% | 12,435 | -2.8% | 0.00% | 0.0% |
| Q2 2023 | $284,755 | +2.8% | 12,798 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $276,880 | -2.0% | 12,783 | -8.1% | 0.00% | 0.0% |
| Q4 2022 | $282,492 | -8.0% | 13,909 | +15.9% | 0.00% | 0.0% |
| Q3 2022 | $307,000 | +5.1% | 11,998 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $292,000 | -34.2% | 12,321 | -37.5% | 0.00% | 0.0% |
| Q1 2022 | $444,000 | -6.1% | 19,713 | -17.5% | 0.00% | 0.0% |
| Q4 2021 | $473,000 | +59.3% | 23,885 | +58.4% | 0.00% | 0.0% |
| Q3 2021 | $297,000 | -51.7% | 15,081 | -46.0% | 0.00% | -50.0% |
| Q2 2021 | $615,000 | -11.3% | 27,934 | -4.1% | 0.00% | 0.0% |
| Q1 2021 | $693,000 | +12.5% | 29,124 | +23.6% | 0.00% | 0.0% |
| Q4 2020 | $616,000 | +158.8% | 23,562 | +72.6% | 0.00% | +100.0% |
| Q3 2020 | $238,000 | -4.4% | 13,649 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $249,000 | +30.4% | 14,775 | -6.5% | 0.00% | 0.0% |
| Q4 2019 | $191,000 | 0.0% | 15,807 | +17.1% | 0.00% | 0.0% |
| Q3 2019 | $191,000 | +28.2% | 13,494 | +1.1% | 0.00% | 0.0% |
| Q2 2019 | $149,000 | -6.9% | 13,350 | -2.0% | 0.00% | 0.0% |
| Q1 2019 | $160,000 | -9.6% | 13,627 | +2.9% | 0.00% | 0.0% |
| Q4 2018 | $177,000 | -13.7% | 13,243 | -9.4% | 0.00% | 0.0% |
| Q3 2018 | $205,000 | -18.3% | 14,618 | -8.4% | 0.00% | -50.0% |
| Q2 2018 | $251,000 | +4.6% | 15,956 | +9.3% | 0.00% | 0.0% |
| Q1 2018 | $240,000 | -18.9% | 14,605 | -11.0% | 0.00% | 0.0% |
| Q4 2017 | $296,000 | +240.2% | 16,408 | +36.7% | 0.00% | +100.0% |
| Q4 2016 | $87,000 | +50.0% | 11,999 | +16.4% | 0.00% | 0.0% |
| Q1 2015 | $58,000 | +70.6% | 10,308 | -10.0% | 0.00% | – |
| Q4 2014 | $34,000 | -40.4% | 11,457 | -46.0% | 0.00% | -100.0% |
| Q3 2014 | $57,000 | -21.9% | 21,201 | -18.5% | 0.00% | 0.0% |
| Q2 2014 | $73,000 | -68.9% | 26,000 | -51.8% | 0.00% | -66.7% |
| Q1 2014 | $235,000 | +343.4% | 53,896 | +60.3% | 0.00% | +200.0% |
| Q3 2013 | $53,000 | -3.6% | 33,625 | +4.9% | 0.00% | 0.0% |
| Q2 2013 | $55,000 | – | 32,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |